|
🐜
|
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection
23 auth.
M. Rudwaleit,
D. Heijde,
R. Landewé,
J. Listing,
N. Akkoç,
J. Brandt,
Jürgen Braun,
C. Chou,
E. Collantes-Estévez,
M. Dougados,
...
F. Huang,
J. Gu,
M. Khan,
Y. Kirazlı,
W. Maksymowych,
H. Mielants,
I. Sørensen,
S. Ozgoçmen,
E. Roussou,
R. Valle-Oñate,
U. Weber,
J. Wei,
J. Sieper
|
11 |
2009 |
11
🐜
|
|
🐜
|
The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general
19 auth.
M. Rudwaleit,
D. Heijde,
R. Landewé,
N. Akkoç,
J. Brandt,
C. Chou,
M. Dougados,
F. Huang,
J. Gu,
Y. Kirazlı,
...
F. Bosch,
I. Olivieri,
E. Roussou,
S. Scarpato,
I. Sørensen,
R. Valle-Oñate,
U. Weber,
J. Wei,
J. Sieper
|
10 |
2010 |
10
🐜
|
|
🐜
|
Clinical efficacy and safety of etanercept versus sulfasalazine in patients with ankylosing spondylitis: a randomized, double-blind trial.
7 auth.
J. Braun,
I. E. van der Horst-Bruinsma,
F. Huang,
R. Burgos-Vargas,
B. Vlahos,
A. Koenig,
...
B. Freundlich
|
7 |
2011 |
7
🐜
|
|
🐜
|
ASAS/WHO ICF Core Sets for ankylosing spondylitis (AS): how to classify the impact of AS on functioning and health
9 auth.
A. Boonen,
J. Braun,
I. Bruinsma,
F. Huang,
W. Maksymowych,
N. Kostanjsek,
...
A. Cieza,
G. Stucki,
D. Heijde
|
6 |
2009 |
6
🐜
|
|
🐜
|
Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity.
11 auth.
C. Chen,
K. Lin,
D. T. Y. Yu,
C. Yang,
F. Huang,
H. Chen,
...
T. Liang,
H. Liao,
C. Tsai,
J. C. C. Wei,
C. Chou
|
6 |
2006 |
6
🐜
|
|
🦁
|
Efficacy and safety of adalimumab in Chinese adults with active ankylosing spondylitis: results of a randomised, controlled trial
12 auth.
F. Huang,
J. Gu,
P. Zhu,
C. Bao,
Jian-hua Xu,
Huji Xu,
...
Huaxiang Wu,
Guochun Wang,
Q. Shi,
N. Andhivarothai,
Jaclyn K Anderson,
A. Pangan
|
6 |
2013 |
6
🦁
|
|
🐢
|
Sleep disturbances are associated with increased pain, disease activity, depression, and anxiety in ankylosing spondylitis: a case-control study
Yan Li,
Shengli Zhang,
Jian Zhu,
Xu-na Du,
F. Huang
|
6 |
2012 |
6
🐢
|
|
🦁
|
One-year open-label trial of thalidomide in ankylosing spondylitis.
F. Huang,
J. Gu,
Wei Zhao,
Jian Zhu,
Jianglin Zhang,
David T. Y. Yu
|
6 |
2002 |
6
🦁
|
|
🐜
|
Serum levels of matrix metalloproteinase 3 and macrophage colony-stimulating factor 1 correlate with disease activity in ankylosing spondylitis.
11 auth.
Chun-hua Yang,
J. Gu,
M. Rihl,
D. Baeten,
F. Huang,
Mian-song Zhao,
...
Hanwei Zhang,
W. Maksymowych,
F. de Keyser,
E. Veys,
David T. Y. Yu
|
6 |
2004 |
6
🐜
|
|
🐜
|
Predictive validity of the ASAS classification criteria for axial and peripheral spondyloarthritis after follow-up in the ASAS cohort: a final analysis
26 auth.
A. Sepriano,
R. Landewé,
D. M. van der Heijde,
J. Sieper,
N. Akkoç,
J. Brandt,
J. Braun,
E. Collantes-Estévez,
M. Dougados,
O. FitzGerald,
F. Huang,
J. Gu,
Y. Kirazlı,
W. Maksymowych,
H. Marzo-Ortega,
...
I. Olivieri,
S. Ozgoçmen,
E. Roussou,
S. Scarpato,
I. Sørensen,
R. Valle-Oñate,
F. E. Van den Bosch,
I. E. van der Horst-Bruinsma,
U. Weber,
J. Wei,
M. Rudwaleit
|
5 |
2016 |
5
🐜
|
|
🐜
|
Safety and efficacy of golimumab in Chinese patients with active ankylosing spondylitis: 1-year results of a multicentre, randomized, double-blind, placebo-controlled phase III trial.
7 auth.
C. Bao,
F. Huang,
M. Khan,
K. Fei,
Zhong Wu,
Chenglong Han,
...
E. Hsia
|
5 |
2014 |
5
🐜
|
|
🐢
|
Idiopathic retroperitoneal fibrosis (RPF): clinical features of 61 cases and literature review
Kunpeng Li,
Jian Zhu,
Jianglin Zhang,
F. Huang
|
5 |
2011 |
5
🐢
|
